Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 for Postoperative Pain After Bunionectomy
NCT03295721Phase 3Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Oct 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine + meloxicam in postoperative pain (3 arms), sponsored by Heron Therapeutics, Inc. Primary endpoint: Mean Area Under the Curve of the Numeric Rating Scale Pain Intensity Scores With Activity Through 72 Hours Postsurgery Compared With Saline Placebo. Started Oct 2017; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03295721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03295721.